In accordance with §§ 130a para. 8/-130c Abs. 1 Sgb W To medicinal products With the active substance Natalizumab (l04aa23,) S.c. dosage form Within the framework of an open-house model.
In accordance with §§ 130a para. 8/-130c Abs. 1 Sgb W To medicinal products With the active ingredient Betamethason And antibiotics (d07cc01) Within the framework of an open-house model.